Jeffrey Scott Cole insider trades
Open-market stock purchases and sales by Jeffrey Scott Cole, Chief Operating Officer at Cadrenal Therapeutics, Inc, from SEC Form 4 filings since Apr 2, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 9, 2026 | CVKD Cadrenal Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CVKD Cadrenal Therapeutics, Inc: other filings, last Oct 9, 2026